Cancer Screening & Wellness Checkup - Premium Package

One Test - Comprehensive Screening Solution

Detect Early-Stage Cancer with ctDNA (SPOT-MAS)*

The test utilizes next-generation sequencing (NGS) technology integrated with artificial intelligence (AI) to detect the presence and predict the potential location of tumors within the body.

Detection of 10 common cancer types**

Detection sensitivity up to 10 times higher than traditional blood-based tumor biomarkers [1,2]

**Simultaneous screening for 10 types of cancer: Breast, Lung, Stomach, Liver – Biliary Tract, Colorectal, Head – Neck, Endometrial, Ovarian, Pancreatic, Esophageal Cancer.

1. Nguyen, L.H.D., Nguyen, T.H.H. et al. Prospective validation study: a non-invasive circulating tumor DNA-based assay for simultaneous early detection of multiple cancers in asymptomatic adults. BMC Med 23, 90 (2025)
2. Sekiguchi, M., & Matsuda, T. (2020). Limited usefulness of serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for gastrointestinal and whole-body

Wellness Checkup Diamond

Liver

Heart

Lipid

Diabetes

Kidney

Thyroid

Nutrition

Hematology

PSCs offering
FREE home sample collection

WHY EARLY CANCER & HEALTH SCREENING MATTERS?

DIABETES

50% of Patients Are Unaware

By the time it is diagnosed, serious complications such as cardiovascular damage, neuropathy, kidney failure, or blindness may have already occurred

CANCER

80% of Cases Are Diagnosed at Late Stage

Many patients miss the “Window of Opportunity” for effective treatment

LIVER

Hepatitis B/C

Can remain silent for 15 - 20 years without noticeable symptoms, yet may progress to cirrhosis, liver failure, or liver cancer if undetected

HEART DISEASE

80% of Strokes Occur Unexpectedly

Cholesterol levels can increase quietly over 10 - 20 years

PREMIUM PACKAGE OF CANCER SCREENING & WELLNESS CHECKUP

One Single Blood Collection

Receive a Complete Early Cancer Detection Solution
with A Comprehensive Health Evaluation

EARLY SCREENING

Common Cancers with ctDNA Technology

This cutting-edge test applies next-generation sequencing combined with artificial intelligence to analyze circulating tumor DNA (ctDNA) - small fragments of genetic material released by cancer cells into the bloodstream - enabling detection and localization of tumors at their earliest stages

Exceptional Specificity: 99.71% accuracy - minimizing false-positive results

Scope

Simultaneous detection of 10 common cancer types in a single test:

01 Breast Cancer

02 Lung Cancer

03 Stomach Cancer

04 Liver - Biliary Tract Cancer

05 Colorectal Cancer

06 Ovarian Cancer

07 Pancreatic Cancer

08 Esophageal Cancer

09 Endometrial Cancer

10 Head & Neck Cancer

Simplicity

A non-invasive procedure requiring only one 10 mL blood draw, with no special preparation needed

Specificity

99.8% cancer-free probability when the result is negative

Early Stage

Up to 71% of cancer cases can be identified at early stages

Superior PPV

The positive predictive value is 10 times higher than conventional tests - meaning that a positive result is far more likely to represent true cancer, reducing unnecessary invasive diagnostic procedures

Smart Technology

Integration of advanced genomic sequencing and AI signal amplification allows ultra-sensitive detection, even when tumor-derived DNA signals are weak in the early-stage

EVALUATE

Health Indicators

The package covers 38 critical biomarkers in the body, including indicators for Diabetes, Kidney, Liver, Micronutrients, Cardiovascular Health, Thyroid Function, Hematology, Viral Hepatitis.

Provide a comprehensive health map to personalize lifestyle and nutrition

Physiological Parameters

02-04

Diabetes

02. Fasting Blood Glucose
03. HbA1c
04. Estimated Average Glucose

05-09

Kidney Function

05. Uric Acid
06. Creatinine
07. Estimated Glomerular Filtration Rate (eGFR)

08. Urea
09. Urinalysis

10-18

Liver Function

10. Aspartate Aminotransferase (ASAT / SGOT)
11. Alanine Aminotransferase (ALAT / SGPT)
12. Gamma-Glutamyl Transferase (GGT)

13. Total Bilirubin

14. Direct Bilirubin
15. Indirect Bilirubin
16. Alkaline Phosphatase
17. Albumin
18. Total Protein

19-26

Cardiovascular

19. Total Cholesterol
20. LDL Cholesterol
21. HDL Cholesterol
22. Triglycerides
23. Non-HDL Cholesterol
24. Cholesterol/HDL Ratio
25. Homocysteine
26. hs CRP

27-30

Hematology

27. Complete Blood Count (CBC)
28. Iron
29. Ferritin
30. Vitamin B12

31-33

Nutrition

31. Calcium
32. 25-OH Vitamin D
33. Phosphorus

34-35

Thyroid Function

34. Thyroid Stimulating Hormone (TSH)
35. Free Thyroxine (FT4)

36-38

Viral Hepatitis

36. HBsAg (Qualitative)
37. HBsAb
38. Anti-HCV

IDEAL CANDIDATES

High-risk Substance Users

Individuals with a history of long-term smoking (≥ 20 pack/years) or frequent alcohol and stimulant use

Individuals with Liver Disease Risk Factors

Individuals diagnosed with Hepatitis B or C, or those at high risk of liver cirrhosis and liver cancer

Genetic Risk Group

Individuals with a family history of cancer or chronic diseases such as cardiovascular disease, diabetes, kidney disorders, etc.

Carriers of Hereditary Cancer Syndromes

Individuals carrying hereditary gene mutations associated with cancer

Periodic Screening Group

Individuals requiring regular health monitoring due to family history of cancer or chronic conditions (cardiovascular, metabolic, renal diseases, etc.)

Lifestyle Risk Group

Individuals with unhealthy lifestyle habits: sedentary behavior, poor dietary patterns

Toxic Exposure Group

Individuals living or working in hazardous environments

SPECIAL OFFERS

A Meaningful Health Gift for You and Your Family

Screening for 10 common cancers prevalent in Vietnam

Evaluation of 38 essential health indicators

Home sample collection

Free retesting in cases of borderline ctDNA cancer screening results

Up to 6,000,000 VND financial support for advanced diagnostic imaging - histopathological biopsy if a positive cancer result is detected

Frequently Asked Questions

1. How does the effectiveness of the ctDNA Cancer Screening Test compare with other cancer screening methods?

2. Who should NOT undergo ctDNA Cancer Screening Test?

Individuals who already diagnosed with cancer within the past 5 years
Individuals showing strong clinical suspicion of cancer
- Individuals with lung, liver, or breast lesions rated LUNG-RADS / LI-RADS / RAD-BI ≥ 4
- Individuals with polyps ≥ 1cm or ulcerative / nodular lesions with malignancy potential found during gastrointestinal endoscopy
Pregnant women
Individuals with a history of bone marrow transplantation or recent whole-blood transfusion (within the last 3 months)
Individuals presenting symptoms or physical findings highly suggestive of cancer. These cases should undergo clinical evaluation and diagnostic testing under a physician’s supervision rather than screening

3. Which cancer types can the ctDNA Cancer Screening Test detect?

The ctDNA Cancer Screening Test is capable of detecting 10 common cancer types at an early stage, including: Breast, Lung, Liver & Biliary Tract, Stomach, Colorectal, Ovarian, Pancreatic, Esophageal, Endometrial, Head & Neck cancers.

4. Can ctDNA Cancer Screening Test detect early-stage cancer?

Yes. The ctDNA Cancer Screening can help detect cancer at an early stage by analyzing circulating tumor DNA (ctDNA) – tiny fragments of genetic material released by cancer cells into the bloodstream.

5. What is the procedure for ctDNA Cancer Screening Test?

The ctDNA screening process has three steps:

Step 1: Schedule an appointment: Customers can leave their information on our website or contact the DIAG hotline at 1900 1717.
Step 2: Blood sample collection: A 10 mL blood sample will be collected at DIAG’s PSCs.
Step 3: Receive results: Results are available in approximately 22 working days, followed by a personalized consultation with a DIAG physician.

6. Can ctDNA Cancer Screening Test be performed periodically?

Yes. The ctDNA Cancer Screening Test can be performed periodically, especially for individuals at high risk of cancer. Depending on your doctor’s recommendation and overall health status, the test may be repeated annually or at a customized interval.

7. Is the ctDNA Cancer Screening Test covered by health insurance?

Health insurance currently does not cover the cost of the ctDNA Cancer Screening Test. However, DIAG is actively collaborating with insurance providers to offer coverage options in the near future.

8. Is the ctDNA Cancer Screening Test at DIAG confidential?

DIAG Medical Center guarantees complete confidentiality for all patient information. All laboratory data and results are securely stored and protected in compliance with international data protection standards.

:star: ID Bài Viết:

*DIAG is authorized by Gene Solutions to offer the genetic sequencing test using Next-Generation Sequencing technology (SPOT-MAS 10)

which is approved by the Ho Chi Minh City Department of Health under Decision No. 1147/QĐ-SYT

Recently Searched